Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
AFTER being overshadowed last year by the boom in big pharmaceutical mergers, biotechnology deals are kicking off 2015. The first large drug transaction of the year was Shire Plc's agreement on Sunday to buy rare-disease treatment developer NPS Pharmaceuticals Inc for US$5.2...